My prayer and mission is to help women of all ages know what to look for with Ovarian Cancer and encourage them to go to the ...

Findings from a multi-institutional, international study have significantly advanced the understanding of genetic alterations in the BRCA2 gene, a key player in hereditary cancer risk.

The already crowded field of biomarker-targeted drugs is poised to only get busier with new biomarkers, ADCs, and cancer vaccines.

Findings from a multi-institutional, international study led by researchers from the Mayo Clinic Comprehensive Cancer Center ...